Sensitization to apoptosis underlies KrasD12-dependent oncolysis of murine C26 colorectal carcinoma cells by reovirus T3D.
about
Clinical development of reovirus for cancer therapy: An oncolytic virus with immune-mediated antitumor activityExploring Reovirus Plasticity for Improving Its Use as Oncolytic VirusPotential for Improving Potency and Specificity of Reovirus Oncolysis with Next-Generation Reovirus VariantsModification of mammalian reoviruses for use as oncolytic agentsReovirus exerts potent oncolytic effects in head and neck cancer cell lines that are independent of signalling in the EGFR pathway.Isolation of reovirus T3D mutants capable of infecting human tumor cells independent of junction adhesion molecule-A.Immunosuppression promotes reovirus therapy of colorectal liver metastases.Targeting cancer-initiating cells with oncolytic viruses.Stabilisation of p53 enhances reovirus-induced apoptosis and virus spread through p53-dependent NF-κB activationReovirus variants with mutations in genome segments S1 and L2 exhibit enhanced virion infectivity and superior oncolysis.Reovirus-based therapy for cancer.Changing faces in virology: the dutch shift from oncogenic to oncolytic viruses.Reduction of virion-associated σ1 fibers on oncolytic reovirus variants promotes adaptation toward tumorigenic cells.Replicating reoviruses with a transgene replacing the codons for the head domain of the viral spike.Oncolytic virus therapy for cancer.CUG2, a novel oncogene confers reoviral replication through Ras and p38 signaling pathway.Inflammatory tumour cell killing by oncolytic reovirus for the treatment of melanomaTransient infection of freshly isolated human colorectal tumor cells by reovirus T3D intermediate subviral particles.Baculovirus-assisted Reovirus Infection in Monolayer and Spheroid Cultures of Glioma cells.Going (Reo)Viral: Factors Promoting Successful Reoviral Oncolytic Infection
P2860
Q26750568-D456FF2A-8E1F-4A6F-B489-CD4A633F3002Q26771799-6781CDE6-66EB-456F-9B1B-5E38769F0177Q26775033-FC529981-BD30-4BCE-BE33-6B65F03F3CDEQ28264900-9BB4C890-4A8B-4806-8247-DF40AB2161F6Q34393001-CA4EB7F2-D8EA-4A46-A3DB-C71E9B599ED6Q34460916-FB391D11-67DA-419E-98BD-C412F96106B8Q34502982-DA3D0058-B728-41DD-B254-9CE89A47D9D3Q34659011-1F19E897-62A1-43F8-AE9E-0BF3FC5CC1AAQ35262964-017366C7-AE72-43B8-975C-531BB6B5D536Q36155535-0E4814D8-FB90-485C-BDB8-A698A61A606FQ37519640-3D9E7094-EA1B-4BBA-AC39-8F51FABA39C8Q38241666-CFEF83BE-C83A-45CD-AE37-729CAFF0D7FCQ38912745-B334AC1D-E622-4281-AE49-2CDB40B79BB7Q38920004-C20DCDAE-A4CD-41AA-9F6D-0E5FD1E12F28Q38924529-DED4AC75-8157-445D-BE52-E81F7C551C35Q39751677-4BE3B718-D58D-4C90-9078-1E437D95589FQ39874999-DE3178FD-7946-455E-9448-40694FBD67D5Q40015289-7D91C937-A417-4C74-B855-B031468A41C4Q47132045-EFE2E3C9-0D01-4413-BF56-E60A3A5EB41EQ56986466-B7A05F94-7C0A-4950-8C81-F4C13363A0BA
P2860
Sensitization to apoptosis underlies KrasD12-dependent oncolysis of murine C26 colorectal carcinoma cells by reovirus T3D.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Sensitization to apoptosis und ...... rcinoma cells by reovirus T3D.
@en
Sensitization to apoptosis und ...... rcinoma cells by reovirus T3D.
@nl
type
label
Sensitization to apoptosis und ...... rcinoma cells by reovirus T3D.
@en
Sensitization to apoptosis und ...... rcinoma cells by reovirus T3D.
@nl
prefLabel
Sensitization to apoptosis und ...... rcinoma cells by reovirus T3D.
@en
Sensitization to apoptosis und ...... rcinoma cells by reovirus T3D.
@nl
P2093
P2860
P1433
P1476
Sensitization to apoptosis und ...... rcinoma cells by reovirus T3D.
@en
P2093
Diana J M van den Wollenberg
Inne H M Borel Rinkes
Niels Smakman
Onno Kranenburg
P2860
P304
14981-14985
P356
10.1128/JVI.79.23.14981-14985.2005
P407
P50
P577
2005-12-01T00:00:00Z